Search

everythinglearnresearchcommunity

for

Search:↓

A boy's hair loss improved after tumor removal and vitamin D treatment, but hair loss returned despite normal vitamin D and no tumor regrowth.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

Human stem cells can aid stroke recovery, research experiences boost students' career aspirations, minoxidil may reduce cancer spread, a molecule can slow tumor growth, a protein affects water flow in cells, magnesium behaves differently at tiny scales, and a new method detects slow-moving objects.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Pilomatrixoma involves abnormal hair keratin production and cell death, causing debris and cysts.

Biological therapy boosts the immune system to effectively fight melanoma.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Keratoacanthoma changes as it grows, showing different hair follicle characteristics at each stage.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Inactive hair follicle stem cells help prevent skin cancer.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.